Biomarkers Characterization of Circulating Tumour Cells in Breast Cancer Patients Full Text
Breast Cancer Research, 05/04/2012
Nadal RM et al. – This is the largest exploratory circulating tumour cells (CTCs) biomarker analysis in nonmetastatic BC patients. The study suggests that CTCs biomarkers profiles might be useful as a surrogate marker for therapeutic selection and monitoring since heterogeneity of the biomarkers distribution in CTCs and the lack of correlation with the primary tumor biomarker status were found.